Is Bydureon long acting or short acting? Understanding Exenatide Formulations
•
4 min read
According to Drugs.com, Bydureon BCise is an extended-release formulation of exenatide that is injected once weekly for the treatment of Type 2 diabetes. This definitively answers the question, **Is Bydureon long acting or short acting?** by confirming its long-acting nature. Its long-acting profile is what differentiates it from its short-acting counterpart, Byetta, which contains the same active ingredient.
